{"id":"https://openalex.org/W3172399401","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","title":"CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.","display_name":"CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.","publication_year":2021,"publication_date":"2021-05-20","ids":{"openalex":"https://openalex.org/W3172399401","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","mag":"3172399401"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.15_suppl.9093","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007462622","display_name":"Xiuning Le","orcid":"https://orcid.org/0000-0002-8554-1185","observed_orcids":["https://orcid.org/0000-0002-8554-1185","https://orcid.org/0009-0003-5164-3567"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiuning Le","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091509029","display_name":"Marina Chiara Garassino","orcid":"https://orcid.org/0000-0002-3821-5598","observed_orcids":["https://orcid.org/0000-0002-3821-5598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Chiara Garassino","raw_affiliation_strings":["National Cancer Institute, IRCCS, Department of Medical Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, IRCCS, Department of Medical Oncology, Milan, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051331698","display_name":"Robin Cornelissen","orcid":"https://orcid.org/0000-0002-4289-3092","observed_orcids":["https://orcid.org/0000-0002-4289-3092"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robin Cornelissen","raw_affiliation_strings":["Erasmus Medical Center, Rotterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasmus Medical Center, Rotterdam, Netherlands;","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I2799648416","display_name":"AdventHealth Orlando","ror":"https://ror.org/02n1cyj49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799648416"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["Advent Health Hematology and Oncology, Orlando, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advent Health Hematology and Oncology, Orlando, FL;","institution_ids":["https://openalex.org/I2799648416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090445265","display_name":"Nishan Tchekmedyian","orcid":"https://orcid.org/0000-0003-1298-0993","observed_orcids":["https://orcid.org/0000-0003-1298-0993"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nishan Tchekmedyian","raw_affiliation_strings":["Pacific Shores Medical Group, Huntington Beach, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pacific Shores Medical Group, Huntington Beach, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038755935","display_name":"Julian R. Molina","orcid":"https://orcid.org/0000-0002-9962-4635","observed_orcids":["https://orcid.org/0000-0002-9962-4635"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julian R. Molina","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058265665","display_name":"Christina S. Baik","orcid":"https://orcid.org/0009-0007-0822-9060","observed_orcids":["https://orcid.org/0009-0007-0822-9060"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina S Baik","raw_affiliation_strings":["Seattle Cancer Care Alliance, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Cancer Care Alliance, Seattle, WA;","institution_ids":["https://openalex.org/I1332479046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083337698","display_name":"Sharon Leu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152715","display_name":"Spectrum Pharmaceuticals (United States)","ror":"https://ror.org/050473r14","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152715"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Leu","raw_affiliation_strings":["Spectrum Pharmaceuticals, Irvine, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Spectrum Pharmaceuticals, Irvine, CA;","institution_ids":["https://openalex.org/I4210152715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072401254","display_name":"Lyndah K. Dreiling","orcid":"https://orcid.org/0009-0003-0134-733X","observed_orcids":["https://orcid.org/0009-0003-0134-733X"]},"institutions":[{"id":"https://openalex.org/I4210152715","display_name":"Spectrum Pharmaceuticals (United States)","ror":"https://ror.org/050473r14","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152715"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lyndah Dreiling","raw_affiliation_strings":["Spectrum Pharmaceuticals, Irvine, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Spectrum Pharmaceuticals, Irvine, CA;","institution_ids":["https://openalex.org/I4210152715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091668678","display_name":"Francois M. Lebel","orcid":"https://orcid.org/0000-0002-1216-6185","observed_orcids":["https://orcid.org/0000-0002-1216-6185"]},"institutions":[{"id":"https://openalex.org/I4210152715","display_name":"Spectrum Pharmaceuticals (United States)","ror":"https://ror.org/050473r14","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152715"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francois M. Lebel","raw_affiliation_strings":["Spectrum Pharmaceuticals, Irvine, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Spectrum Pharmaceuticals, Irvine, CA;","institution_ids":["https://openalex.org/I4210152715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070881158","display_name":"Jeffrey Melson Clarke","orcid":"https://orcid.org/0000-0001-5647-0245","observed_orcids":["https://orcid.org/0000-0001-5647-0245"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Melson Clarke","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"15_suppl","first_page":"9093","last_page":"9093"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/poziotinib","display_name":"poziotinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/egfr-exon-20-insertion-mutation","display_name":"EGFR exon 20 insertion","score":0.8980000019073486},{"id":"https://openalex.org/keywords/her2-exon-20-insertion","display_name":"HER2 exon 20 insertion","score":0.9980000257492065},{"id":"https://openalex.org/keywords/central-nervous-system-metastases","display_name":"central nervous system metastasis","score":0.7440000176429749},{"id":"https://openalex.org/keywords/intracranial-response","display_name":"intracranial response","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.5960000157356262},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.8220000267028809},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7789999842643738},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.8289999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7540000081062317},{"id":"https://openalex.org/keywords/central-nervous-system-penetration","display_name":"CNS penetration","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9121683835983276},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6459894776344299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6384598016738892},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6145381331443787},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5909608602523804},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5480390787124634},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.49551236629486084},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2164699137210846},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.15_suppl.9093","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.9093","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309055","display_name":"Spectrum Pharmaceuticals","ror":"https://ror.org/050473r14"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3031575375","https://openalex.org/W3088045239","https://openalex.org/W3082739148","https://openalex.org/W3148715585","https://openalex.org/W3203727420","https://openalex.org/W2767428437","https://openalex.org/W2898137622","https://openalex.org/W3088902561","https://openalex.org/W2737875386","https://openalex.org/W3138654081"],"abstract_inverted_index":{"9093":[0],"Background:":[1],"Treatment":[2],"addressing":[3],"non-small":[4],"cell":[5],"lung":[6],"cancer":[7],"(NSCLC)":[8],"harboring":[9,79],"EGFR":[10,106,119,132,329,373],"or":[11,107,330,374],"HER2":[12,108,125,331,375],"exon":[13,56,80,109,332,376],"20":[14,57,81,110,333,377],"insertion":[15,82,111],"mutations":[16,83,112,334,378],"remains":[17],"an":[18,85,172],"unmet":[19],"need.":[20],"These":[21],"tumors":[22],"are":[23],"associated":[24],"with":[25,45,77,102,136,151,227,328,369,382],"a":[26,38,46,228,266,273,284,363],"high":[27],"incidence":[28],"of":[29,54,185,213,231,269,275,341],"CNS":[30,65,73,138,260,314,324,346,383],"metastases":[31,139,384],"and":[32,67,99,105,128,191,221,224,242,251,272,288,296,305,311,348,379],"unfavorable":[33],"survival":[34],"rates.":[35],"Poziotinib":[36,144,320],"is":[37],"potent,":[39],"irreversible,":[40],"tyrosine":[41],"kinase":[42],"inhibitor":[43],"(TKI)":[44],"structure":[47],"that":[48,257,359,371,385],"can":[49],"overcome":[50],"the":[51,55,206,263,342],"steric":[52],"hindrance":[53],"limited":[58],"binding":[59],"pocket.":[60],"Preclinical":[61],"data":[62,357],"suggest":[63,358],"poziotinib":[64,72,360],"penetration,":[66],"here":[68],"we":[69],"show":[70],"meaningful":[71,323,364],"activity":[74,325],"in":[75,84,113,248,280,298,303,316,326,335],"patients":[76,101,135,215,247,256,301,327,343,350,368],"NSCLC":[78,104,255,370],"ongoing":[86],"multi-cohort,":[87],"multi-center":[88],"Phase":[89],"2":[90,123],"study":[91],"(ZENITH20;":[92],"NCT03318939).":[93],"Methods:":[94],"ZENITH20":[95,336],"enrolled":[96],"previously":[97,120,126,198],"treated":[98,127],"na\u00efve":[100],"advanced/metastatic":[103],"several":[114],"cohorts:":[115],"Cohort":[116,122,129],"1":[117],"(C1)":[118],"treated;":[121],"(C2)":[124],"3":[130,217,294],"(C3)":[131],"treatment-na\u00efve.":[133],"All":[134],"stable":[137,289],"at":[140],"baseline":[141,259],"were":[142,234],"included.":[143],"(16":[145],"mg)":[146],"was":[147,161,202,239,291],"administered":[148],"orally":[149],"QD,":[150],"follow-up":[152,238],"for":[153,245,367],"up":[154],"to":[155],"24":[156],"months.":[157],"The":[158,236,339,355],"primary":[159],"endpoint":[160],"Objective":[162],"Response":[163,186],"Rate":[164,182],"(ORR)":[165],"evaluated":[166],"centrally":[167],"using":[168],"RECIST":[169,208],"v1.1":[170],"by":[171],"independent":[173],"image":[174],"review":[175],"committee.":[176],"Secondary":[177],"endpoints":[178],"included":[179],"Disease":[180],"Control":[181],"(DCR),":[183],"Duration":[184],"(DOR),":[187],"Progression-Free":[188],"Survival":[189],"(PFS)":[190],"safety.":[192],"Primary":[193],"efficacy":[194],"results":[195],"have":[196,386],"been":[197],"released.":[199],"Intracranial":[200],"response":[201,287],"determined":[203],"based":[204],"on":[205],"modified":[207],"criteria.":[209],"Results:":[210],"A":[211],"total":[212],"284":[214],"across":[216,293],"cohorts":[218,295],"(C1":[219],"n=115;":[220],"C2":[222,317],"n=90;":[223],"C3":[225,306],"n=79)":[226],"median":[229,237],"age":[230],"60.5":[232],"years":[233],"enrolled.":[235],"7.3,":[240],"8.3,":[241],"9.2":[243],"months":[244],"all":[246],"C1,":[249],"C2,":[250],"C3,":[252],"respectively.":[253],"In":[254],"had":[258,283,307,313,344,351],"lesions":[261],"(N=36),":[262],"analysis":[264],"showed":[265],"patient-based":[267],"ORR":[268],"22.2%":[270],"(8/36)":[271],"DCR":[274],"88.9%":[276],"(32/36).":[277],"One":[278],"patient":[279],"each":[281,302],"cohort":[282],"complete":[285,353],"intracranial":[286,352],"disease":[290,309],"80.6%":[292],"92.9%":[297],"C2.":[299],"Two":[300],"C1":[304],"progressive":[308],"(PD)":[310],"none":[312],"progression":[315,347],"(Table).":[318],"Conclusions:":[319],"exhibited":[321],"clinically":[322],"Cohorts":[337],"1-3.":[338],"majority":[340],"no":[345],"3/36":[349],"responses.":[354],"preliminary":[356],"may":[361],"provide":[362],"treatment":[365],"alternative":[366],"harbor":[372],"who":[380],"present":[381],"poor":[387],"prognosis.":[388],"Clinical":[389],"trial":[390],"information:":[391],"NCT03318939.":[392],"[Table:":[393],"see":[394],"text]":[395]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2021-06-22T00:00:00"}